Characterization of a novel mouse model of multiple myeloma and its use in preclinical therapeutic assessment.
To aid preclinical development of novel therapeutics for myeloma, an in vivo model which recapitulates the human condition is required. An important feature of such a model is the interaction of myeloma cells with the bone marrow microenvironment, as this interaction modulates tumour activity and pr...
Saved in:
| Main Authors: | Rosemary A Fryer, Timothy J Graham, Emma M Smith, Simon Walker-Samuel, Gareth J Morgan, Simon P Robinson, Faith E Davies |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2013-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0057641&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Genetic Architecture of Multiple Myeloma
by: Steven M. Prideaux, et al.
Published: (2014-01-01) -
Preclinical evaluation of the CD38‐targeting engineered toxin body MT‐0169 against multiple myeloma
by: Wassilis S. C. Bruins, et al.
Published: (2024-11-01) -
Preclinical activity of allogeneic SLAMF7-specific CAR T-cells (UCARTCS1) in multiple myeloma
by: Roman Galetto, et al.
Published: (2024-07-01) -
Advanced quantification pipeline reveals new spatial and temporal tumor characteristics in preclinical multiple myeloma
by: Zhixin Sun, et al.
Published: (2025-07-01) -
The perspectives of interleukin-10 in the pathogenesis and therapeutics of multiple myeloma
by: Cheng-Der Liu, et al.
Published: (2021-01-01)